269 related articles for article (PubMed ID: 33579790)
1. Oncogenetic landscape of lymphomagenesis in coeliac disease.
Cording S; Lhermitte L; Malamut G; Berrabah S; Trinquand A; Guegan N; Villarese P; Kaltenbach S; Meresse B; Khater S; Dussiot M; Bras M; Cheminant M; Tesson B; Bole-Feysot C; Bruneau J; Molina TJ; Sibon D; Macintyre E; Hermine O; Cellier C; Asnafi V; Cerf-Bensussan N;
Gut; 2022 Mar; 71(3):497-508. PubMed ID: 33579790
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II.
Soderquist CR; Lewis SK; Gru AA; Vlad G; Williams ES; Hsiao S; Mansukhani MM; Park DC; Bacchi CE; Alobeid B; Green PH; Bhagat G
Am J Surg Pathol; 2021 Jul; 45(7):905-916. PubMed ID: 33544565
[TBL] [Abstract][Full Text] [Related]
3. Refractory celiac disease and EATL patients show severe malnutrition and malabsorption at diagnosis.
Wierdsma NJ; Nijeboer P; de van der Schueren MA; Berkenpas M; van Bodegraven AA; Mulder CJ
Clin Nutr; 2016 Jun; 35(3):685-91. PubMed ID: 25979847
[TBL] [Abstract][Full Text] [Related]
4. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
Cheminant M; Bruneau J; Malamut G; Sibon D; Guegan N; van Gils T; Cording S; Trinquand A; Verkarre V; Lhermitte L; Brousse N; Jannot AS; Khater S; Frenzel L; Delarue R; Suarez F; Marçais A; Mulder CJ; Macintyre E; Asnafi V; Pouyet L; Bonnafous C; Lhospice F; Molina TJ; Meresse B; Cellier C; Cerf-Bensussan N; Hermine O;
Gut; 2019 Aug; 68(8):1396-1405. PubMed ID: 30448772
[TBL] [Abstract][Full Text] [Related]
5. A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease.
Hrdlickova B; Mulder CJ; Malamut G; Meresse B; Platteel M; Kamatani Y; Ricaño-Ponce I; van Wanrooij RLJ; Zorro MM; Jan Bonder M; Gutierrez-Achury J; Cellier C; Zhernakova A; Nijeboer P; Galan P; Withoff S; Lathrop M; Bouma G; Xavier RJ; Jabri B; Bensussan NC; Wijmenga C; Kumar V
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):828-837. PubMed ID: 29787419
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of Enteropathy-Associated T Cell Lymphoma.
Chander U; Leeman-Neill RJ; Bhagat G
Curr Hematol Malig Rep; 2018 Aug; 13(4):308-317. PubMed ID: 29943210
[TBL] [Abstract][Full Text] [Related]
7. Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease.
Hussein S; Gindin T; Lagana SM; Arguelles-Grande C; Krishnareddy S; Alobeid B; Lewis SK; Mansukhani MM; Green PHR; Bhagat G
J Clin Pathol; 2018 Sep; 71(9):825-831. PubMed ID: 29703761
[TBL] [Abstract][Full Text] [Related]
8. Update on the Pathogenesis of Enteropathy-Associated T-Cell Lymphoma.
Abdullah SAA; Goa P; Vandenberghe E; Flavin R
Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627888
[TBL] [Abstract][Full Text] [Related]
9. Origin and immunophenotype of aberrant IEL in RCDII patients.
Tack GJ; van Wanrooij RL; Langerak AW; Tjon JM; von Blomberg BM; Heideman DA; van Bergen J; Koning F; Bouma G; Mulder CJ; Schreurs MW
Mol Immunol; 2012 Apr; 50(4):262-70. PubMed ID: 22364936
[TBL] [Abstract][Full Text] [Related]
10. Complications of coeliac disease.
Malamut G; Cellier C
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):451-8. PubMed ID: 26060109
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Schmitz F; Tjon JM; van Bergen J; Koning F
Mol Immunol; 2014 Mar; 58(1):10-6. PubMed ID: 24252355
[TBL] [Abstract][Full Text] [Related]
12. Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II.
Schmitz F; Tjon JM; Lai Y; Thompson A; Kooy-Winkelaar Y; Lemmers RJ; Verspaget HW; Mearin ML; Staal FJ; Schreurs MW; Cupedo T; Langerak AW; Mulder CJ; van Bergen J; Koning F
Gut; 2013 Apr; 62(4):509-19. PubMed ID: 22760007
[TBL] [Abstract][Full Text] [Related]
13. Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.
Moffitt AB; Ondrejka SL; McKinney M; Rempel RE; Goodlad JR; Teh CH; Leppa S; Mannisto S; Kovanen PE; Tse E; Au-Yeung RKH; Kwong YL; Srivastava G; Iqbal J; Yu J; Naresh K; Villa D; Gascoyne RD; Said J; Czader MB; Chadburn A; Richards KL; Rajagopalan D; Davis NS; Smith EC; Palus BC; Tzeng TJ; Healy JA; Lugar PL; Datta J; Love C; Levy S; Dunson DB; Zhuang Y; Hsi ED; Dave SS
J Exp Med; 2017 May; 214(5):1371-1386. PubMed ID: 28424246
[TBL] [Abstract][Full Text] [Related]
14. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis.
Malamut G; El Machhour R; Montcuquet N; Martin-Lannerée S; Dusanter-Fourt I; Verkarre V; Mention JJ; Rahmi G; Kiyono H; Butz EA; Brousse N; Cellier C; Cerf-Bensussan N; Meresse B
J Clin Invest; 2010 Jun; 120(6):2131-43. PubMed ID: 20440074
[TBL] [Abstract][Full Text] [Related]
15. Therapy in RCDII: Rationale for Combination Strategies?
Nijeboer P; Malamut G; Bouma G; Cerf-Bensussan N; Koning F; van Bergen J; Cellier C; Mulder CJJ
Dig Dis; 2015; 33(2):227-230. PubMed ID: 25925927
[TBL] [Abstract][Full Text] [Related]
16. CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes.
Kooy-Winkelaar YM; Bouwer D; Janssen GM; Thompson A; Brugman MH; Schmitz F; de Ru AH; van Gils T; Bouma G; van Rood JJ; van Veelen PA; Mearin ML; Mulder CJ; Koning F; van Bergen J
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E980-E989. PubMed ID: 28049849
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic Findings of Enteropathy-Associated T-Cell Lymphoma Type II: A Case Series.
Hong YS; Woo YS; Park G; Lee K; Kang SH; Lee HW; Kim ER; Hong SN; Chang DK; Kim YH; Rhee PL; Kim JJ
Gut Liver; 2016 Jan; 10(1):147-51. PubMed ID: 26260757
[TBL] [Abstract][Full Text] [Related]
18. Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study.
Tack GJ; van Wanrooij RL; Von Blomberg BM; Amini H; Coupe VM; Bonnet P; Mulder CJ; Schreurs MW
BMC Gastroenterol; 2012 Nov; 12():159. PubMed ID: 23145841
[TBL] [Abstract][Full Text] [Related]
19. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
[TBL] [Abstract][Full Text] [Related]
20. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.
Chan JK; Chan AC; Cheuk W; Wan SK; Lee WK; Lui YH; Chan WK
Am J Surg Pathol; 2011 Oct; 35(10):1557-69. PubMed ID: 21921780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
